OVERVIEW

Communicable Diseases & Immunisation Conference (CDIC) 2023 is organized by Public Health Association of Australia (PHAA), Inc and will be held from Jun 19 - 21, 2023 at Perth Convention And Exhibition Centre, Perth, Western Australia, Australia.

2023 the Conference theme will be: “Adapting to a new landscape for infectious disease prevention and control”.

Conference Objectives:
The Objectives of the conference are to:
• Create a dynamic environment to foster knowledge sharing, collaboration, and relationship building among health professionals working on communicable disease control, vaccination, and related areas
• Highlight the activities of relevant research programs on infectious and vaccine-preventable diseases to encourage engagement in high-quality research initiatives to improve health outcomes for Australians
• Provide collective guidance and insight into capacity building and strengthening communicable disease control and immunization programs
• Provide conference delegates with new and innovative ideas that can be applied to local settings and systems to help create and improve public health systems for local communities

Conference Topics:
The program will provide lively and productive discussions and contributions from Australian professionals engaged in Communicable Disease Control and Immunisation. We invite you to submit abstracts under the following session topics:
• Aboriginal health – determinants, strengthening communities, service delivery
• Cross-cultural and social determinants of health, including attitudes and behavior change
• Global and regional infectious disease control and prevention; esp. Asia-Pacific
• One Health – broad approach - environmental, vets, one health experts
• Surveillance and data systems
• Emerging and re-emerging infectious diseases and zoonoses; inc. JE and Monkey Pox
• COVID-19 and COVID-19 Vaccines
• Influenza and other respiratory infections;
• Sexually transmissible and bloodborne infections;
• Enteric and foodborne infections;
• Vaccine-Preventable Diseases,
• Vaccine programs and implementation, emerging immunization practices
• New vaccines – platform technology, COVID-19, RSV, Group B strep
• Public health and clinical workforce – surge and beyond
• Antimicrobial resistance surveillance and public health microbiology